Morgan Freret, MD, PhD
Radiation Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Metastatic Disease
- Intensity Modulated Radiation Therapy (IMRT)
- Image-Guided Radiation Therapy (IGRT)
Request an Appointment
About Me
- Instructor
A radiation oncologist is a cancer doctor with special training in using radiation therapy (RT) to treat cancer with radiation.
My Specialties
- Metastatic Disease
- Intensity Modulated Radiation Therapy (IMRT)
- Image-Guided Radiation Therapy (IGRT)
- Volumetric Arc Therapy (VMAT)
Education
- MD, Harvard Medical School
- PhD, Neuroscience, Harvard Medical School
Residencies
- Radiation Oncology, Memorial Sloan Kettering Cancer Center
Awards and Honors
- Louis V. Gerstner, Jr. Physician Scholars Award (2022)
- Residents/Fellows in Biology Seed Grant, American Society for Radiation Oncology (ASTRO) (2022)
- National Comprehensive Cancer Network (NCCN) Oncology Fellows Program (2022)
- B. Leonard Holman Research Pathway Postdoctoral Fellowship Award, American Board of Radiology (2021)
- Dean's Award for Academic Achievement, Stanford University (2010)
- Graduation with Honors and Distinction, Stanford University (2010)
- Phi Beta Kappa Society (2009)
- Vice Provost for Undergraduate Education (VPUE) Research in Biology Grant, Stanford University (2007)
- National Merit Scholar (2005)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, HMO
MSK has a tentative agreement with Cigna to continue coverage in 2024.
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Freret sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
See all Radiation Oncology doctors
See all External Beam Radiotherapy Service, Manhattan doctors
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
View a list of Dr. Freret’s publications.
Freret ME, Wijetunga NA, Shamseddine AA, Higginson DS, Schmitt AM, Yamada Y, Lis E, Boire A, Yang JT, Xu AJ. Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery. Adv Radiat Oncol. 2022 Dec 26;8(2):101154. doi: 10.1016/j.adro.2022.101154. PMID: 36845624; PMCID: PMC9943781.
Senft RA, Freret ME, Sturrock N, Dymecki SM. Neurochemically and Hodologically Distinct Ascending VGLUT3 versus Serotonin Subsystems Comprise the r2-Pet1 Median Raphe. J Neurosci. 2021 Mar 24;41(12):2581-2600. doi: 10.1523/JNEUROSCI.1667-20.2021. Epub 2021 Feb 5. PMID: 33547164; PMCID: PMC8018730.
Read more
Freret ME, Gutmann DH. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1. J Neurosci Res. 2019 Jan;97(1):45-56. doi: 10.1002/jnr.24250. Epub 2018 Apr 28. PMID: 29704429; PMCID: PMC6766750.
Freret ME, Anastasaki C, Gutmann DH. Independent NF1 mutations underlie café-au-lait macule development in a woman with segmental NF1. Neurol Genet. 2018 Jul 23;4(4):e261. doi: 10.1212/NXG.0000000000000261. PMID: 30065955; PMCID: PMC6066364.
Okaty BW, Freret ME, Rood BD, Brust RD, Hennessy ML, deBairos D, Kim JC, Cook MN, Dymecki SM. Multi-Scale Molecular Deconstruction of the Serotonin Neuron System. Neuron. 2015 Nov 18;88(4):774-91. doi: 10.1016/j.neuron.2015.10.007. Epub 2015 Nov 5. PMID: 26549332; PMCID: PMC4809055.
Visit PubMed for a full listing of Dr. Freret’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.